{"gene":"TGM2","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2006,"finding":"GPR56 (an adhesion GPCR) binds specifically to tissue transglutaminase TG2 in the extracellular matrix, and this interaction mediates suppression of melanoma tumor growth and metastasis; GPR56 associates in a complex with Gαq and the tetraspanin CD81","method":"Binding assay, overexpression/knockdown in melanoma cells, xenograft tumor models","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assay, in vivo xenograft validation, replicated in follow-up study (PMID:24356421)","pmids":["16757564"],"is_preprint":false},{"year":2013,"finding":"GPR56 internalizes and degrades extracellular TG2, thereby reducing fibronectin deposition and focal adhesion kinase accumulation; TG2 crosslinking activity promotes melanoma growth, while GPR56 antagonizes this by clearing TG2","method":"Xenograft studies in immunodeficient Tg2−/− mice, internalization/degradation assays, fibronectin deposition analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — clean genetic model (Tg2 KO mice), multiple orthogonal readouts, mechanistic follow-up of PMID:16757564","pmids":["24356421"],"is_preprint":false},{"year":2006,"finding":"TG2 associates with β1 and β5 integrins on the cell surface of drug-resistant breast cancer cells and promotes fibronectin-mediated focal adhesion kinase activation, conferring an apoptosis-resistant phenotype; siRNA knockdown of TG2 inhibits fibronectin-mediated cell attachment and survival","method":"Co-immunoprecipitation (TG2 with β1/β5 integrins), siRNA knockdown, cell survival assays on fibronectin-coated surfaces","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of TG2–integrin complex, siRNA KD with defined phenotype, multiple cell lines","pmids":["16449978"],"is_preprint":false},{"year":2009,"finding":"TG2 acts as a G protein mediating intracellular signaling by the α1b-adrenergic receptor in hepatocytes; TG2 knockout mice show increased hepatocyte sensitivity to Fas-mediated apoptosis due to impaired adrenergic signaling and decreased Bcl-xL expression","method":"TG2 knockout mouse model, in vivo and in vitro anti-Fas antibody treatment, Bcl-xL expression analysis","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — genetic KO model with defined molecular phenotype (impaired AR signaling, reduced Bcl-xL), replicated in vitro and in vivo","pmids":["16108039"],"is_preprint":false},{"year":2009,"finding":"TG2 transamidating/crosslinking activity stimulates NF-κB activation in fibroblasts, leading to increased TGFβ1 expression and secretion, which in turn elevates collagen and fibronectin synthesis and deposition; nitric oxide suppresses TG2 activity and reverses this pro-fibrotic cascade","method":"Tetracycline-inducible TG2 expression system in Swiss 3T3 fibroblasts, site-directed TG inhibitors, NF-κB reporter assay, TGFβ1 ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — inducible expression system, site-directed inhibitor, multiple orthogonal readouts (NF-κB reporter, ELISA, Western blot)","pmids":["19657147"],"is_preprint":false},{"year":2011,"finding":"TG2 transamidating activity is the primary biochemical function regulating both apoptosis and autophagy; the transamidation-inactive C277S mutant fails to suppress caspase-3/PARP cleavage during apoptosis and fails to catalyze final steps of autophagosome formation","method":"TG2 knockout MEF reconstitution with wild-type or C277S transamidation-inactive mutant, apoptosis and autophagy induction assays, LC3-II immunoblot","journal":"Amino acids","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis reconstitution in KO cells, multiple orthogonal readouts (caspase-3, PARP, LC3-II)","pmids":["21479826"],"is_preprint":false},{"year":2010,"finding":"TG2 directly interacts with β3 integrins on the cell surface (confirmed by immunoprecipitation), acting as a co-receptor for fibronectin; catalytically active TG2 (but not the transamidation-inactive Cys277Ser mutant) activates TGFβ1 and increases fibronectin deposition, enhancing cell adhesion and reducing migration","method":"Stable transfection of CT26 cells with wild-type or Cys277Ser TG2, immunoprecipitation of TG2–β3 integrin complex, TGFβ1 measurement, migration assays, site-directed TG inhibitors","journal":"Amino acids","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis + Co-IP + multiple functional assays in a defined cell model","pmids":["21046178"],"is_preprint":false},{"year":2013,"finding":"TG2 directly binds and crosslinks S100A4, and acts as a substrate enzyme for S100A4 (confirmed by Co-IP, Far Western blotting, and crosslinking assays); TG2-mediated S100A4 crosslinking promotes cell migration through syndecan-4 and α5β1 integrin co-signaling pathways linked by PKCα activation","method":"Co-immunoprecipitation, Far Western blotting, in vitro crosslinking assay, shRNA knockdown, TG2-specific inhibitors (cell-permeable and non-cell-permeable), functional blocking antibodies","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding and substrate confirmed by multiple orthogonal methods, pathway dissected with specific reagents","pmids":["23469180"],"is_preprint":false},{"year":2015,"finding":"TG2 binds cell surface syndecan-4; inhibition of TG2 transamidating activity by a cell-permeable fluorescent inhibitor blocks TG2 binding to syndecan-4, inhibits TG2 translocation into the extracellular matrix, and reduces fibronectin deposition, cell motility, and cord formation in endothelial cells","method":"Cell-permeable fluorescently labeled peptidomimetic TG2 inhibitor, in situ TG2 activity assay, fibronectin deposition analysis, cell motility assays, Matrigel cord formation, mouse model of nephrosclerosis","journal":"Chemistry & biology","confidence":"High","confidence_rationale":"Tier 2 — specific tool compound with direct binding and functional consequences shown in vitro and in vivo","pmids":["26456735"],"is_preprint":false},{"year":2012,"finding":"PKA-induced phosphorylation of TG2 at serine-216 is required for TG2-mediated NF-κB activation, Akt activation, and PTEN downregulation; a TG2 mutant lacking the Ser216 phosphorylation site (m-TG2) fails to activate NF-κB, fails to promote Akt phosphorylation, and fails to downregulate PTEN","method":"TG2 null MEF reconstitution with wild-type or S216A TG2, db-cAMP (PKA activator) treatment, NF-κB reporter assay, Akt immunoblot, PTEN mRNA and protein quantification, MCF-7/T-47D validation","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 — site-directed mutation in KO-reconstitution system, multiple readouts, single lab","pmids":["22759359"],"is_preprint":false},{"year":2018,"finding":"TG2, via its protein disulfide isomerase (PDI) activity, triggers trimerization and nuclear translocation of HSF1 and enables HSF1 DNA binding to the HSP70 promoter; TG2 loss impairs HSF1 nuclear translocation and HSP70 induction during proteotoxic stress","method":"TG2 loss-of-function (KO/KD), nuclear fractionation, HSF1 DNA binding assay (ChIP/EMSA), cystic fibrosis mouse model lacking TG2, CFTR functional measurement","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (nuclear fractionation, DNA binding, in vivo KO model, functional CFTR readout)","pmids":["29752334"],"is_preprint":false},{"year":2022,"finding":"TGM2 installs serotonin onto glutamine-5 of histone H3 (H3Q5ser) via its transamidase activity; histone serotonylation by TGM2 is excluded from constitutive heterochromatic regions because higher-order chromatin structures impose a steric barrier to TGM2 activity, and accessibility rather than primary sequence or pre-existing PTMs dictates TGM2 substrate selectivity at chromatin","method":"Biochemical reconstitution with purified TGM2 and nucleosome substrates, DNA-barcoded nucleosome libraries, structure-activity relationship studies, mammalian cell chromatin localization (histone mark profiling)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with defined substrates, SAR studies, orthogonal cell-based validation","pmids":["36256821"],"is_preprint":false},{"year":2020,"finding":"TGM2 promotes formation of mitochondria-associated ER membranes (MAMs) under high-glucose conditions; TGM2 silencing inhibits IP3R1–VDAC1 interactions, preventing mitochondrial calcium influx, mitochondrial ROS accumulation, and amyloid beta production in neuronal cells","method":"TGM2 siRNA knockdown, Co-IP of IP3R1–VDAC1, mitochondrial calcium measurement (Fluo-4AM), mtROS quantification, streptozotocin diabetic mouse model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with Co-IP and calcium measurements, in vivo mouse model, single lab","pmids":["32704090"],"is_preprint":false},{"year":2020,"finding":"TG2 mediates serotonylation of SERCA2 (sarco-endoplasmic reticulum Ca2+ ATPase) under hypoxic conditions; TG2-mediated SERCA2 serotonylation inhibits SERCA2 activity, increases cytosolic Ca2+ via TRPC6-dependent store-operated calcium entry, and promotes pulmonary vascular smooth muscle cell proliferation; vascular smooth muscle-specific TG2 knockout prevents hypoxic pulmonary hypertension in mice","method":"Co-immunoprecipitation of serotonylated SERCA2, TG2 overexpression/silencing, Fluo-4AM intracellular calcium measurement, vascular smooth muscle-specific Tgm2−/− mouse model, RVSP/RVHI measurement","journal":"Frontiers in pharmacology","confidence":"High","confidence_rationale":"Tier 2 — Co-IP demonstrating direct modification, tissue-specific KO mouse model, multiple functional readouts","pmids":["32116663"],"is_preprint":false},{"year":2016,"finding":"TG2 forms complexes with NF-κB components and drives constitutive NF-κB activation; under stress, TG2 and NF-κB induce IL-6 production, which in turn activates autophagy to promote mantle cell lymphoma cell survival; ATG5 positively feeds back on the TG2/NF-κB/IL-6 axis","method":"CRISPR-mediated TG2 silencing, TG2 overexpression, autophagy flux assays, IL-6 ELISA, NF-κB reporter, ATG5 modulation, in vivo lymphoma models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR KO with multiple pathway readouts, in vivo validation, single lab","pmids":["27488529"],"is_preprint":false},{"year":2022,"finding":"After irradiation, TGM2 is transported from the cell membrane to lysosomes by SDC1, and then TGM2 binds LC3 through two LC3-interacting regions (LIRs), coordinating autophagosome-lysosome fusion by enabling EPG5 recognition of LC3 and stabilizing the STX17-SNAP29-VAMP8 SNARE complex; SDC1-TGM2-FLOT1-BHMT form a complex that maintains autophagic flux in irradiated GBM cells","method":"Co-immunoprecipitation, tandem mass tag proteomic analysis, mRFP-GFP-LC3 autophagy flux assay, immunofluorescence, transmission electron microscopy, LIR mutagenesis (implied), in vivo GBM mouse model","journal":"Autophagy / Theranostics","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of multi-protein complex, multiple orthogonal methods (TEM, flux assay, proteomics), in vivo validation, replicated across two publications","pmids":["35913916","37441590"],"is_preprint":false},{"year":2022,"finding":"Cytosolic TGM2 promotes gastric cancer progression through its GTP-binding enzymatic activity by facilitating dissociation of the ubiquitin E3 ligase TRIM21 from STAT1, thereby preventing TRIM21-mediated ubiquitination and degradation of STAT1 and maintaining STAT1 protein stability","method":"Co-immunoprecipitation, mass spectrometry identification of TRIM21 as STAT1 E3 ligase, TGM2 GTP-binding mutants, gain/loss-of-function rescue experiments, xenograft and metastasis models, A23187 (Ca2+ ionophore) to modulate TGM2 activity","journal":"Cancer communications (London, England)","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP + MS identification + mutagenesis + in vivo, single lab","pmids":["36353796"],"is_preprint":false},{"year":2016,"finding":"IL-1β induces IL-6 production in TG2-expressing breast cancer cells through NF-κB-, PI3K-, and JNK-dependent mechanisms; TG2 expression is required for this IL-1β-driven IL-6 induction and the resulting increase in invasiveness and estrogen-independent tumor growth","method":"Stable TG2 transfection in MCF7 cells, cytokine stimulation, anti-IL-6/anti-IL-1β antibody neutralization, 3D culture and in vivo mammary fat pad xenograft","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 — defined genetic model (stable transfection) with antibody neutralization and in vivo validation, single lab","pmids":["27609180"],"is_preprint":false},{"year":2016,"finding":"PARP3 promotes TGFβ- and ROS-induced EMT by stimulating a TG2-Snail-E-cadherin axis; PARP3 depletion prevents TGFβ-dependent TG2 induction and downstream Snail upregulation/E-cadherin downregulation","method":"PARP3 siRNA depletion, TGFβ treatment, Western blot for TG2/Snail/E-cadherin, migration and chemoresistance assays, stem cell marker analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 — epistasis established by siRNA KD with defined pathway readouts, single lab","pmids":["27579892"],"is_preprint":false},{"year":2007,"finding":"Missense mutations in TGM2 located close to the catalytic site (M330R, I331N, N333S) impair transamidating activity in vitro and are associated with early-onset type 2 diabetes; TG2 is the only transglutaminase significantly expressed in human pancreatic islet cells","method":"TGM2 gene sequencing in MODY/early-onset T2D patients, in vitro transamidation activity assay of mutant proteins, gene expression analysis of TGM family in pancreatic tissue","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro enzymatic assay of disease-linked mutants, human tissue expression data, controlled comparison with normoglycemic individuals","pmids":["17939176"],"is_preprint":false},{"year":2017,"finding":"TG2 and Factor XIII-A control monocyte-macrophage differentiation into osteoclasts, regulate RANKL production in mesenchymal stem cells and adipocytes, and are required for plasma fibronectin assembly into bone; TG2/FXIII-A double-KO mice show increased osteoclastogenesis, increased bone marrow adipogenesis, and plasma FN retention","method":"TG2/FXIII-A knockout mice, in vitro osteoclastogenesis assay, chemical TG activity inhibition, RANKL/OPG expression, biomechanical bone testing, plasma FN assembly assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — genetic KO model in vivo, in vitro rescue with chemical inhibition, multiple orthogonal cellular and molecular readouts","pmids":["28387755"],"is_preprint":false},{"year":2025,"finding":"TGM2-mediated serotonylation of glutamine-5 on histone H3 (H3Q5ser) promotes HCC progression; transcriptional intermediary factor 1β (TIF1β) mediates recruitment of TGM2 to MYC target gene loci, facilitating H3Q5ser modification and activating MYC pathway transcription","method":"CUT&Tag and RNA sequencing, adeno-associated virus liver-specific TGM2/H3.3 overexpression, TGM2 inhibitor treatment in HCC organoids and xenograft models, hydrodynamic tail vein injection model","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 1–2 — CUT&Tag chromatin profiling, in vivo liver-specific models, TGM2 inhibitor mechanistic validation, multiple model systems","pmids":["39788430"],"is_preprint":false},{"year":2022,"finding":"Weakly migratory breast cancer cells release TG2-enriched microvesicles that activate fibroblasts, leading fibroblast-directed cancer cell migration; microvesicle-TG2 induces tumor stiffening and fibroblast activation in vivo and enhances metastasis of weakly migratory cells","method":"Phenotypic cell sorting, microvesicle isolation and proteomic characterization, in vitro migration assays, in vivo tumor stiffening and metastasis models","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — proteomic identification of TG2 in microvesicles, in vitro and in vivo functional validation, single lab","pmids":["36475545"],"is_preprint":false},{"year":2021,"finding":"TGM2 promotes NF-κB p65 nuclear translocation, which transcriptionally activates fibronectin 1 (FN1); the NEAT1_2 lncRNA sponges miR-491 to regulate TGM2 expression, and TGM2–NFκB–FN1 signaling promotes papillary thyroid cancer invasion and metastasis","method":"TGM2 siRNA knockdown, NF-κB p65 nuclear fractionation, dual-luciferase reporter assay (miR-491 binding to NEAT1_2 and TGM2 3'UTR), Transwell and wound healing assays, lung metastasis mouse model","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 — nuclear fractionation for mechanism, dual-luciferase for upstream regulation, in vivo model, single lab","pmids":["33738254"],"is_preprint":false},{"year":2022,"finding":"In lung-resident neutrophils, prostaglandin E2 (PGE2) acts via protein kinase A (PKA) to induce Tgm2 expression; Tgm2-deficient neutrophils release excessive inflammatory cytokines upon LPS stimulation, and Tgm2−/− mice show exacerbated lung damage in an LPS-induced ARDS model","method":"Tgm2 knockout mice, bronchoalveolar lavage fluid treatment of bone marrow neutrophils, LPS challenge, cytokine ELISA, ARDS model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genetic KO mouse model, defined signaling pathway (PGE2/PKA/Tgm2), in vivo disease model","pmids":["35679477"],"is_preprint":false},{"year":2020,"finding":"Blocking TG2 attenuates bleomycin-induced pulmonary fibrosis by inhibiting EMT; TG2 KD or inhibition suppresses Akt activation, and Akt reactivation (by SC79) rescues the EMT inhibition caused by TG2 knockdown, placing TG2 upstream of Akt in EMT regulation","method":"siRNA knockdown of TG2 in MLE12 alveolar epithelial cells, GK921 TG2 inhibitor, SC79 (Akt activator) rescue experiment, bleomycin mouse model, Western blot for EMT markers","journal":"Respiratory physiology & neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via rescue experiment, in vivo model, single lab","pmids":["32006666"],"is_preprint":false},{"year":2021,"finding":"TGM2 promotes NF-κB signaling in microglia via its GTP-binding activity (not transamidase activity); gain-of-function with transamidase-deficient TGM2 still activates NF-κB and microglial inflammation, whereas GTP-binding-deficient mutant does not","method":"TGM2 siRNA knockdown, gain-of-function with GTP-binding vs. transamidase activity mutants, NF-κB signaling assay, LPS-stimulated BV2 and primary microglia","journal":"Journal of immunology research","confidence":"Medium","confidence_rationale":"Tier 2 — activity-specific mutagenesis dissecting which enzymatic function mediates NF-κB activation, single lab","pmids":["34485533"],"is_preprint":false},{"year":2020,"finding":"AFF1 binds to the promoter region of the Tgm2 gene and directly regulates its transcription; AFF1 inhibition of adipogenic differentiation in mesenchymal stem cells is rescued by Tgm2 overexpression, placing TGM2 downstream of AFF1 in adipogenic regulation","method":"ChIP-qPCR (AFF1 at Tgm2 promoter), RNA-seq, AFF1 siRNA/overexpression, Tgm2 overexpression rescue, Oil Red O staining, in vivo adipose formation","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-qPCR establishes direct transcriptional regulation, epistasis by rescue, single lab","pmids":["32441391"],"is_preprint":false},{"year":2024,"finding":"RSL3-induced oxidative stress promotes S-glutathionylation of TGM2 via upregulation of GSTP1, leading to proteasomal degradation of TGM2; TGM2 normally accumulates in the nucleus after irradiation and interacts with topoisomerase IIα to facilitate DNA repair; loss of TGM2 through this mechanism impairs DNA DSB repair and inhibits EMT","method":"TGM2 overexpression/knockdown, S-glutathionylation assay, nuclear fractionation, TGM2–topoisomerase IIα Co-IP, γ-H2AX foci for DSB quantification, ferroptosis inhibitor controls, xenograft model","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP establishing TGM2–TopIIα interaction, PTM mechanism (S-glutathionylation leading to degradation), nuclear localization with functional consequence, single lab","pmids":["39580966"],"is_preprint":false}],"current_model":"TGM2 is a multifunctional Ca2+-dependent enzyme whose transamidase (crosslinking), GTPase/G-protein, protein disulfide isomerase, and kinase activities operate in distinct subcellular compartments: extracellularly/at the cell surface it crosslinks ECM proteins and acts as a co-receptor for fibronectin through β1/β3/β5 integrins and syndecan-4, promoting cell adhesion and survival signaling via FAK and PKCα; intracellularly it acts as a Gαq-like G protein for adrenergic receptors, activates NF-κB (requiring phosphorylation at Ser216 by PKA), stabilizes STAT1 by blocking TRIM21-mediated ubiquitination (via GTP-binding activity), and regulates proteostasis by facilitating HSF1 trimerization/nuclear translocation through PDI activity; in the nucleus it catalyzes monoaminylation (serotonylation) of histone H3 at Q5 in a steric accessibility-dependent manner to activate transcription, and interacts with topoisomerase IIα to facilitate DNA repair; TGM2 also coordinates autophagosome–lysosome fusion by binding LC3 through LIR motifs; it is regulated extracellularly by GPR56-mediated internalization/degradation, by nitric oxide-induced inactivation, and by S-glutathionylation-triggered proteasomal degradation."},"narrative":{"teleology":[{"year":2006,"claim":"Establishing that TGM2 functions as a cell-surface co-receptor by forming complexes with β1/β5 integrins on cancer cells, linking it mechanistically to fibronectin-mediated FAK activation and drug-resistant survival signaling.","evidence":"Co-immunoprecipitation of TGM2–integrin complexes and siRNA knockdown in drug-resistant breast cancer cells","pmids":["16449978"],"confidence":"High","gaps":["Structural basis of TGM2–integrin interaction unknown","Whether TGM2 transamidase activity is required for integrin binding was not resolved here"]},{"year":2006,"claim":"Identifying GPR56 as an extracellular TGM2-binding partner that suppresses melanoma growth, establishing that TGM2 in the ECM is subject to receptor-mediated regulation rather than acting autonomously.","evidence":"Binding assay and GPR56 overexpression/knockdown in melanoma cells with xenograft validation","pmids":["16757564"],"confidence":"High","gaps":["Mechanism of GPR56-mediated TGM2 clearance not yet defined","Whether this applies beyond melanoma was untested"]},{"year":2009,"claim":"Demonstrating that TGM2 functions as an intracellular G protein for α1b-adrenergic receptor signaling in hepatocytes, establishing a non-transamidase role in protecting against Fas-mediated apoptosis through Bcl-xL expression.","evidence":"TGM2 knockout mouse model with in vivo and in vitro anti-Fas antibody challenge","pmids":["16108039"],"confidence":"High","gaps":["Whether TGM2's G-protein function extends to other GPCRs beyond adrenergic receptors was unclear","Structural basis for GTP hydrolysis by TGM2 not characterized"]},{"year":2009,"claim":"Establishing that TGM2 transamidase activity directly drives NF-κB activation and a downstream pro-fibrotic TGFβ1–collagen–fibronectin cascade, and that nitric oxide inactivates this pathway.","evidence":"Inducible TGM2 expression in fibroblasts with site-directed TG inhibitors, NF-κB reporter, TGFβ1 ELISA","pmids":["19657147"],"confidence":"High","gaps":["Direct NF-κB substrate of TGM2 crosslinking not identified","Whether nitric oxide modification is at the active-site cysteine or allosteric was not resolved"]},{"year":2010,"claim":"Resolving that catalytically active TGM2, but not the Cys277Ser transamidation-deficient mutant, activates TGFβ1 and fibronectin deposition while interacting with β3 integrins, demonstrating that crosslinking activity is essential for ECM remodeling.","evidence":"Stable transfection of wild-type vs. C277S TGM2 mutant, Co-IP of TGM2–β3 integrin complex, functional assays","pmids":["21046178"],"confidence":"High","gaps":["Identity of TGM2's direct crosslinking substrates in the ECM not comprehensively cataloged"]},{"year":2011,"claim":"Using active-site mutagenesis in KO-reconstituted cells to prove that transamidase activity is the primary enzymatic function controlling both anti-apoptotic protection and autophagosome formation.","evidence":"TGM2 KO MEF reconstitution with wild-type or C277S mutant, caspase-3/PARP cleavage and LC3-II readouts","pmids":["21479826"],"confidence":"High","gaps":["Molecular targets crosslinked during autophagosome formation not identified","Relationship to GTP-binding activity in autophagy regulation not dissected"]},{"year":2012,"claim":"Identifying PKA-mediated phosphorylation at Ser216 as a regulatory switch required for TGM2-dependent NF-κB activation, Akt activation, and PTEN downregulation, adding a post-translational control layer to TGM2 signaling.","evidence":"S216A mutant reconstitution in TGM2-null MEFs with db-cAMP treatment, NF-κB reporter, Akt/PTEN readouts","pmids":["22759359"],"confidence":"Medium","gaps":["Whether Ser216 phosphorylation alters TGM2 conformation or protein interactions was not determined","Not independently replicated"]},{"year":2013,"claim":"Demonstrating that GPR56 clears extracellular TGM2 via internalization and degradation, mechanistically linking GPR56 tumor suppression to removal of TGM2-dependent fibronectin deposition and FAK signaling.","evidence":"Xenograft studies in Tgm2⁻/⁻ mice, internalization/degradation assays","pmids":["24356421"],"confidence":"High","gaps":["Endocytic pathway and degradation compartment for TGM2 not specified"]},{"year":2013,"claim":"Establishing S100A4 as both a binding partner and crosslinking substrate of TGM2, with TGM2-mediated S100A4 crosslinking driving cell migration through syndecan-4/α5β1 integrin/PKCα co-signaling.","evidence":"Co-IP, Far Western, in vitro crosslinking, cell-permeable and non-cell-permeable TG2 inhibitors, shRNA knockdown","pmids":["23469180"],"confidence":"High","gaps":["Specific crosslinked S100A4 species identity and stoichiometry not determined"]},{"year":2015,"claim":"Showing that TGM2 transamidase activity is required for TGM2 binding to syndecan-4 and its translocation to the extracellular matrix, establishing syndecan-4 as a gatekeeper for extracellular TGM2 function.","evidence":"Cell-permeable fluorescent peptidomimetic TGM2 inhibitor, fibronectin deposition analysis, in vivo nephrosclerosis model","pmids":["26456735"],"confidence":"High","gaps":["Whether syndecan-4 is a direct transamidation substrate or binding partner is not fully resolved"]},{"year":2016,"claim":"Revealing that TGM2 forms complexes with NF-κB components and drives constitutive NF-κB activation that feeds into IL-6 production and pro-survival autophagy in lymphoma, establishing a TGM2–NF-κB–IL-6–autophagy circuit.","evidence":"CRISPR-mediated TGM2 silencing/overexpression, NF-κB reporter, IL-6 ELISA, autophagy flux, in vivo lymphoma model","pmids":["27488529"],"confidence":"Medium","gaps":["Direct NF-κB subunit modified or bound by TGM2 not identified","ATG5 feedback mechanism on TGM2/NF-κB not mechanistically resolved"]},{"year":2017,"claim":"Establishing that TGM2 and Factor XIII-A jointly regulate osteoclastogenesis, RANKL production, and plasma fibronectin assembly into bone, positioning TGM2 as a key transglutaminase in skeletal homeostasis.","evidence":"TGM2/FXIII-A double-KO mice, in vitro osteoclastogenesis, chemical TG inhibition, biomechanical testing","pmids":["28387755"],"confidence":"High","gaps":["Specific TGM2 substrates in bone matrix not identified","Individual contributions of TGM2 vs. FXIII-A partially confounded by double KO"]},{"year":2018,"claim":"Discovering that TGM2's protein disulfide isomerase activity triggers HSF1 trimerization and nuclear translocation, establishing TGM2 as a proteostasis regulator through a non-transamidase catalytic mechanism.","evidence":"TGM2 KO/KD, nuclear fractionation, HSF1 DNA binding assay, cystic fibrosis mouse model","pmids":["29752334"],"confidence":"High","gaps":["Specific disulfide bonds in HSF1 rearranged by TGM2 not mapped","Whether PDI activity operates constitutively or only under stress not defined"]},{"year":2020,"claim":"Demonstrating that TGM2 promotes mitochondria-associated ER membrane formation under high-glucose conditions by facilitating IP3R1–VDAC1 interactions, linking TGM2 to mitochondrial calcium influx and amyloid beta production in diabetic neurodegeneration.","evidence":"TGM2 siRNA KD, Co-IP of IP3R1–VDAC1, mitochondrial calcium measurement, streptozotocin diabetic mouse model","pmids":["32704090"],"confidence":"Medium","gaps":["Whether TGM2 directly crosslinks or scaffolds IP3R1–VDAC1 not determined","Not independently replicated"]},{"year":2020,"claim":"Identifying SERCA2 as a TGM2 serotonylation substrate whose modification under hypoxia inhibits Ca²⁺ reuptake and drives pulmonary vascular smooth muscle proliferation, with vascular smooth muscle-specific Tgm2 KO preventing pulmonary hypertension.","evidence":"Co-IP of serotonylated SERCA2, tissue-specific Tgm2⁻/⁻ mice, intracellular calcium measurement, RVSP/RVHI readouts","pmids":["32116663"],"confidence":"High","gaps":["Specific glutamine residue(s) on SERCA2 modified by TGM2 not identified","Serotonin source and regulation in pulmonary vasculature not addressed"]},{"year":2021,"claim":"Dissecting which enzymatic activity mediates NF-κB activation in microglia: GTP-binding activity, not transamidase activity, is responsible, establishing that TGM2's contribution to NF-κB signaling is cell-type and activity-dependent.","evidence":"Activity-specific TGM2 mutants (GTP-binding vs. transamidase) in LPS-stimulated BV2 and primary microglia","pmids":["34485533"],"confidence":"Medium","gaps":["Molecular target of TGM2's GTP-binding-dependent NF-κB activation not identified","Single lab finding"]},{"year":2022,"claim":"Establishing that TGM2 catalyzes histone H3Q5 serotonylation in a chromatin accessibility-dependent manner, with higher-order chromatin structure sterically excluding TGM2 from heterochromatin, defining the epigenetic selectivity principle for this modification.","evidence":"Biochemical reconstitution with purified TGM2 and nucleosome substrates, DNA-barcoded nucleosome libraries, mammalian chromatin profiling","pmids":["36256821"],"confidence":"High","gaps":["Reader proteins recognizing H3Q5ser mark not identified in this study","Whether accessibility model extends to other TGM2 histone substrates untested"]},{"year":2022,"claim":"Revealing that TGM2 coordinates autophagosome–lysosome fusion after irradiation by binding LC3 through LIR motifs, enabling EPG5 recognition and stabilizing the STX17–SNAP29–VAMP8 SNARE complex, within an SDC1–TGM2–FLOT1–BHMT complex.","evidence":"Co-IP, tandem mass tag proteomics, mRFP-GFP-LC3 flux assay, TEM, LIR mutagenesis, in vivo GBM model","pmids":["35913916","37441590"],"confidence":"High","gaps":["Whether TGM2 transamidase or GTP-binding activity is required for SNARE complex stabilization not determined","Generalizability beyond irradiation stress context unclear"]},{"year":2022,"claim":"Demonstrating that cytosolic TGM2 stabilizes STAT1 by preventing TRIM21-mediated ubiquitination through its GTP-binding activity, providing a mechanism for TGM2-dependent gastric cancer progression independent of transamidase function.","evidence":"Co-IP, MS identification of TRIM21, GTP-binding mutants, gain/loss-of-function rescue, xenograft models","pmids":["36353796"],"confidence":"Medium","gaps":["Whether TGM2 directly competes with TRIM21 for STAT1 binding or acts allosterically not resolved","Single lab"]},{"year":2022,"claim":"Identifying PGE2/PKA signaling as an upstream inducer of Tgm2 expression in lung-resident neutrophils, with Tgm2 deficiency leading to excessive inflammatory cytokine release and exacerbated lung injury, positioning TGM2 as an anti-inflammatory effector in innate immunity.","evidence":"Tgm2 KO mice, BAL fluid treatment, LPS-induced ARDS model, cytokine ELISA","pmids":["35679477"],"confidence":"High","gaps":["TGM2 substrates mediating cytokine suppression in neutrophils not identified","Whether transamidase or GTP-binding activity mediates the anti-inflammatory effect not tested"]},{"year":2024,"claim":"Showing that S-glutathionylation of TGM2 (via GSTP1 upregulation under oxidative stress) triggers its proteasomal degradation and that nuclear TGM2 interacts with topoisomerase IIα to facilitate DNA double-strand break repair, linking TGM2 turnover to DNA repair competence.","evidence":"S-glutathionylation assay, nuclear fractionation, TGM2–TopIIα Co-IP, γ-H2AX foci quantification, xenograft model","pmids":["39580966"],"confidence":"Medium","gaps":["Mechanism of TGM2–TopIIα cooperation in DNA repair not defined","Whether TGM2 crosslinks or scaffolds TopIIα unclear","Single lab finding"]},{"year":2025,"claim":"Identifying TIF1β as the chromatin recruiter of TGM2 to MYC target gene loci, where TGM2 catalyzes H3Q5 serotonylation to activate MYC pathway transcription in hepatocellular carcinoma, providing the first recruitment mechanism for TGM2's nuclear epigenetic function.","evidence":"CUT&Tag, RNA-seq, liver-specific AAV overexpression, TGM2 inhibitor in HCC organoids and xenografts","pmids":["39788430"],"confidence":"High","gaps":["Whether TIF1β directly binds TGM2 or acts through intermediaries not fully resolved","Genome-wide scope of TIF1β-dependent TGM2 recruitment beyond MYC targets unknown"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for TGM2's conformational switch between transamidase-active (open/Ca²⁺-bound) and GTP-binding (closed) states in living cells; the identity of direct crosslinking substrates during autophagosome formation; how TGM2 is selectively directed to different subcellular compartments (nucleus, cell surface, ECM, MAMs); and the full catalog of serotonylation targets beyond H3Q5 and SERCA2.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in-cell structural data on TGM2 conformational dynamics","Comprehensive substrate profiling for transamidase and serotonylation activities lacking","Mechanism of TGM2 nuclear import undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,6,7,8,11,13,21]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[3,16,26]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,16]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[11,21]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[5,6,7,11,13,21]},{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,6,7,8]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,8,22]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,11,21,28]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,16,26]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[15]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,9,14,17,23,26]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[4,6,7,8]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[5,15]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[11,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[24]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[28]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[10]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[2,6,7]}],"complexes":["TGM2–integrin (β1/β3/β5) cell-surface complex","TGM2–syndecan-4 complex","SDC1–TGM2–FLOT1–BHMT autophagy complex"],"partners":["FN1","SDC4","ITGB1","ITGB3","GPR56","S100A4","TOP2A","LC3"],"other_free_text":[]},"mechanistic_narrative":"TGM2 is a multifunctional enzyme whose Ca²⁺-dependent transamidase, GTP-binding, and protein disulfide isomerase activities operate across distinct subcellular compartments to regulate extracellular matrix homeostasis, cell survival signaling, inflammatory responses, chromatin modification, and autophagy. At the cell surface, TGM2 forms complexes with β1/β3/β5 integrins and syndecan-4 to crosslink extracellular matrix proteins including fibronectin and S100A4, activating FAK- and PKCα-dependent adhesion and survival signaling, while GPR56 opposes this by internalizing and degrading extracellular TGM2 [PMID:16449978, PMID:21046178, PMID:26456735, PMID:24356421]. Intracellularly, TGM2 activates NF-κB through either its transamidase or GTP-binding activity depending on cell type, stabilizes STAT1 by blocking TRIM21-mediated ubiquitination via GTP binding, facilitates HSF1 trimerization and nuclear translocation through PDI activity, and coordinates autophagosome–lysosome fusion by binding LC3 through LIR motifs [PMID:19657147, PMID:34485533, PMID:36353796, PMID:29752334, PMID:35913916]. In the nucleus, TGM2 catalyzes serotonylation of histone H3 at Q5 in a chromatin accessibility-dependent manner—with TIF1β mediating recruitment to MYC target loci—and interacts with topoisomerase IIα to facilitate DNA double-strand break repair [PMID:36256821, PMID:39788430, PMID:39580966]."},"prefetch_data":{"uniprot":{"accession":"P21980","full_name":"Protein-glutamine gamma-glutamyltransferase 2","aliases":["Erythrocyte transglutaminase","Heart G alpha(h)","hhG alpha(h)","Isopeptidase TGM2","Protein G alpha(h)","G(h)","Protein-glutamine deamidase TGM2","Protein-glutamine dopaminyltransferase TGM2","Protein-glutamine histaminyltransferase TGM2","Protein-glutamine noradrenalinyltransferase TGM2","Protein-glutamine serotonyltransferase TGM2","Tissue transglutaminase","tTG","tTgase","Transglutaminase C","TG(C)","TGC","TGase C","Transglutaminase H","TGase H","Transglutaminase II","TGase II","Transglutaminase-2","TG2","TGase-2","hTG2"],"length_aa":687,"mass_kda":77.3,"function":"Calcium-dependent acyltransferase that catalyzes the formation of covalent bonds between peptide-bound glutamine and various primary amines, such as gamma-amino group of peptide-bound lysine, or mono- and polyamines, thereby producing cross-linked or aminated proteins, respectively (PubMed:23941696, PubMed:31991788, PubMed:9252372). Involved in many biological processes, such as bone development, angiogenesis, wound healing, cellular differentiation, chromatin modification and apoptosis (PubMed:1683874, PubMed:27270573, PubMed:28198360, PubMed:7935379, PubMed:9252372). Acts as a protein-glutamine gamma-glutamyltransferase by mediating the cross-linking of proteins, such as ACO2, HSPB6, FN1, HMGB1, RAP1GDS1, SLC25A4/ANT1, SPP1 and WDR54 (PubMed:23941696, PubMed:24349085, PubMed:29618516, PubMed:30458214). Under physiological conditions, the protein cross-linking activity is inhibited by GTP; inhibition is relieved by Ca(2+) in response to various stresses (PubMed:18092889, PubMed:7592956, PubMed:7649299). When secreted, catalyzes cross-linking of proteins of the extracellular matrix, such as FN1 and SPP1 resulting in the formation of scaffolds (PubMed:12506096). Plays a key role during apoptosis, both by (1) promoting the cross-linking of cytoskeletal proteins resulting in condensation of the cytoplasm, and by (2) mediating cross-linking proteins of the extracellular matrix, resulting in the irreversible formation of scaffolds that stabilize the integrity of the dying cells before their clearance by phagocytosis, thereby preventing the leakage of harmful intracellular components (PubMed:7935379, PubMed:9252372). In addition to protein cross-linking, can use different monoamine substrates to catalyze a vast array of protein post-translational modifications: mediates aminylation of serotonin, dopamine, noradrenaline or histamine into glutamine residues of target proteins to generate protein serotonylation, dopaminylation, noradrenalinylation or histaminylation, respectively (PubMed:23797785, PubMed:30867594). Mediates protein serotonylation of small GTPases during activation and aggregation of platelets, leading to constitutive activation of these GTPases (By similarity). Plays a key role in chromatin organization by mediating serotonylation and dopaminylation of histone H3 (PubMed:30867594, PubMed:32273471). Catalyzes serotonylation of 'Gln-5' of histone H3 (H3Q5ser) during serotonergic neuron differentiation, thereby facilitating transcription (PubMed:30867594). Acts as a mediator of neurotransmission-independent role of nuclear dopamine in ventral tegmental area (VTA) neurons: catalyzes dopaminylation of 'Gln-5' of histone H3 (H3Q5dop), thereby regulating relapse-related transcriptional plasticity in the reward system (PubMed:32273471). Regulates vein remodeling by mediating serotonylation and subsequent inactivation of ATP2A2/SERCA2 (By similarity). Also acts as a protein deamidase by mediating the side chain deamidation of specific glutamine residues of proteins to glutamate (PubMed:20547769, PubMed:9623982). Catalyzes specific deamidation of protein gliadin, a component of wheat gluten in the diet (PubMed:9623982). May also act as an isopeptidase cleaving the previously formed cross-links (PubMed:26250429, PubMed:27131890). Also able to participate in signaling pathways independently of its acyltransferase activity: acts as a signal transducer in alpha-1 adrenergic receptor-mediated stimulation of phospholipase C-delta (PLCD) activity and is required for coupling alpha-1 adrenergic agonists to the stimulation of phosphoinositide lipid metabolism (PubMed:8943303) Has cytotoxic activity: is able to induce apoptosis independently of its acyltransferase activity","subcellular_location":"Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P21980/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TGM2","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TGM2","total_profiled":1310},"omim":[{"mim_id":"620826","title":"WD REPEAT-CONTAINING PROTEIN 54; WDR54","url":"https://www.omim.org/entry/620826"},{"mim_id":"613900","title":"TRANSGLUTAMINASE 6; TGM6","url":"https://www.omim.org/entry/613900"},{"mim_id":"609969","title":"SUPRABASIN","url":"https://www.omim.org/entry/609969"},{"mim_id":"604110","title":"ADHESION G PROTEIN-COUPLED RECEPTOR G1; ADGRG1","url":"https://www.omim.org/entry/604110"},{"mim_id":"603805","title":"TRANSGLUTAMINASE 5; TGM5","url":"https://www.omim.org/entry/603805"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"blood vessel","ntpm":775.7}],"url":"https://www.proteinatlas.org/search/TGM2"},"hgnc":{"alias_symbol":["TGC","TG2"],"prev_symbol":[]},"alphafold":{"accession":"P21980","domains":[{"cath_id":"2.60.40.10","chopping":"5-137","consensus_level":"high","plddt":94.0627,"start":5,"end":137},{"cath_id":"3.90.260.10","chopping":"158-458","consensus_level":"high","plddt":92.909,"start":158,"end":458},{"cath_id":"2.60.40.10","chopping":"472-582","consensus_level":"high","plddt":92.1609,"start":472,"end":582},{"cath_id":"2.60.40.10","chopping":"588-683","consensus_level":"high","plddt":95.3997,"start":588,"end":683}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21980","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21980-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21980-F1-predicted_aligned_error_v6.png","plddt_mean":92.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TGM2","jax_strain_url":"https://www.jax.org/strain/search?query=TGM2"},"sequence":{"accession":"P21980","fasta_url":"https://rest.uniprot.org/uniprotkb/P21980.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21980/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21980"}},"corpus_meta":[{"pmid":"16757564","id":"PMC_16757564","title":"GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16757564","citation_count":225,"is_preprint":false},{"pmid":"21902810","id":"PMC_21902810","title":"Extracellular TG2: emerging functions and regulation.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21902810","citation_count":164,"is_preprint":false},{"pmid":"32704090","id":"PMC_32704090","title":"Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32704090","citation_count":140,"is_preprint":false},{"pmid":"33845796","id":"PMC_33845796","title":"Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.","date":"2021","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33845796","citation_count":125,"is_preprint":false},{"pmid":"16449978","id":"PMC_16449978","title":"Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16449978","citation_count":122,"is_preprint":false},{"pmid":"16146777","id":"PMC_16146777","title":"Tissue transglutaminase (TG2)--a wound response enzyme.","date":"2006","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/16146777","citation_count":101,"is_preprint":false},{"pmid":"21818567","id":"PMC_21818567","title":"TG2, a novel extracellular protein with multiple functions.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21818567","citation_count":97,"is_preprint":false},{"pmid":"31570702","id":"PMC_31570702","title":"MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31570702","citation_count":97,"is_preprint":false},{"pmid":"32480093","id":"PMC_32480093","title":"Tunable bioactivity and mechanics of collagen-based tissue engineering constructs: A comparison of EDC-NHS, genipin and TG2 crosslinkers.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/32480093","citation_count":91,"is_preprint":false},{"pmid":"27609180","id":"PMC_27609180","title":"IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27609180","citation_count":87,"is_preprint":false},{"pmid":"29355739","id":"PMC_29355739","title":"Nicotine induces apoptosis in human osteoblasts via a novel mechanism driven by H2O2 and entailing Glyoxalase 1-dependent MG-H1 accumulation leading to TG2-mediated NF-kB desensitization: Implication for smokers-related osteoporosis.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29355739","citation_count":84,"is_preprint":false},{"pmid":"18174247","id":"PMC_18174247","title":"The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18174247","citation_count":82,"is_preprint":false},{"pmid":"10942890","id":"PMC_10942890","title":"Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.","date":"2000","source":"Cytometry","url":"https://pubmed.ncbi.nlm.nih.gov/10942890","citation_count":77,"is_preprint":false},{"pmid":"27579892","id":"PMC_27579892","title":"PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27579892","citation_count":71,"is_preprint":false},{"pmid":"19657147","id":"PMC_19657147","title":"Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19657147","citation_count":70,"is_preprint":false},{"pmid":"25215932","id":"PMC_25215932","title":"Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.","date":"2014","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25215932","citation_count":68,"is_preprint":false},{"pmid":"20395409","id":"PMC_20395409","title":"A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors.","date":"2010","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/20395409","citation_count":67,"is_preprint":false},{"pmid":"24356421","id":"PMC_24356421","title":"GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24356421","citation_count":59,"is_preprint":false},{"pmid":"23276939","id":"PMC_23276939","title":"TGM2 and implications for human disease: role of alternative splicing.","date":"2013","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/23276939","citation_count":59,"is_preprint":false},{"pmid":"36353796","id":"PMC_36353796","title":"Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.","date":"2022","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36353796","citation_count":56,"is_preprint":false},{"pmid":"23877317","id":"PMC_23877317","title":"TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.","date":"2013","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23877317","citation_count":56,"is_preprint":false},{"pmid":"35913916","id":"PMC_35913916","title":"SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/35913916","citation_count":52,"is_preprint":false},{"pmid":"27488529","id":"PMC_27488529","title":"TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27488529","citation_count":51,"is_preprint":false},{"pmid":"28056186","id":"PMC_28056186","title":"Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network.","date":"2017","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/28056186","citation_count":48,"is_preprint":false},{"pmid":"26456735","id":"PMC_26456735","title":"Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.","date":"2015","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/26456735","citation_count":45,"is_preprint":false},{"pmid":"31010374","id":"PMC_31010374","title":"TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31010374","citation_count":44,"is_preprint":false},{"pmid":"17314516","id":"PMC_17314516","title":"GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17314516","citation_count":43,"is_preprint":false},{"pmid":"36639156","id":"PMC_36639156","title":"Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36639156","citation_count":43,"is_preprint":false},{"pmid":"16108039","id":"PMC_16108039","title":"Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.","date":"2005","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16108039","citation_count":43,"is_preprint":false},{"pmid":"27270573","id":"PMC_27270573","title":"Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes.","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27270573","citation_count":42,"is_preprint":false},{"pmid":"21479826","id":"PMC_21479826","title":"TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21479826","citation_count":42,"is_preprint":false},{"pmid":"23499501","id":"PMC_23499501","title":"Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma.","date":"2013","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23499501","citation_count":42,"is_preprint":false},{"pmid":"23469180","id":"PMC_23469180","title":"The role of TG2 in regulating S100A4-mediated mammary tumour cell migration.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23469180","citation_count":41,"is_preprint":false},{"pmid":"26622499","id":"PMC_26622499","title":"Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.","date":"2015","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26622499","citation_count":40,"is_preprint":false},{"pmid":"29752334","id":"PMC_29752334","title":"TG2 regulates the heat-shock response by the post-translational modification of HSF1.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29752334","citation_count":39,"is_preprint":false},{"pmid":"28387755","id":"PMC_28387755","title":"Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28387755","citation_count":39,"is_preprint":false},{"pmid":"18794325","id":"PMC_18794325","title":"Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.","date":"2008","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18794325","citation_count":38,"is_preprint":false},{"pmid":"22160259","id":"PMC_22160259","title":"Recent advances in the development of tissue transglutaminase (TG2) inhibitors.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22160259","citation_count":37,"is_preprint":false},{"pmid":"33738254","id":"PMC_33738254","title":"The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33738254","citation_count":35,"is_preprint":false},{"pmid":"17939176","id":"PMC_17939176","title":"Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17939176","citation_count":34,"is_preprint":false},{"pmid":"35679477","id":"PMC_35679477","title":"Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35679477","citation_count":33,"is_preprint":false},{"pmid":"34902811","id":"PMC_34902811","title":"N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34902811","citation_count":33,"is_preprint":false},{"pmid":"37441590","id":"PMC_37441590","title":"SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.","date":"2023","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/37441590","citation_count":32,"is_preprint":false},{"pmid":"28832669","id":"PMC_28832669","title":"TGC repeat expansion in the TCF4 gene increases the risk of Fuchs' endothelial corneal dystrophy in Australian cases.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28832669","citation_count":32,"is_preprint":false},{"pmid":"30015899","id":"PMC_30015899","title":"TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30015899","citation_count":30,"is_preprint":false},{"pmid":"33435987","id":"PMC_33435987","title":"Circular RNA circ_0081001 knockdown enhances methotrexate sensitivity in osteosarcoma cells by regulating miR-494-3p/TGM2 axis.","date":"2021","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/33435987","citation_count":28,"is_preprint":false},{"pmid":"22759359","id":"PMC_22759359","title":"Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.","date":"2012","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22759359","citation_count":28,"is_preprint":false},{"pmid":"36256821","id":"PMC_36256821","title":"TGM2-mediated histone transglutamination is dictated by steric accessibility.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36256821","citation_count":28,"is_preprint":false},{"pmid":"37246171","id":"PMC_37246171","title":"Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.","date":"2023","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37246171","citation_count":27,"is_preprint":false},{"pmid":"31035965","id":"PMC_31035965","title":"CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.","date":"2019","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31035965","citation_count":26,"is_preprint":false},{"pmid":"22652528","id":"PMC_22652528","title":"Tissue transglutaminase (TG-2) modified amniotic membrane: a novel scaffold for biomedical applications.","date":"2012","source":"Biomedical materials (Bristol, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22652528","citation_count":26,"is_preprint":false},{"pmid":"32116663","id":"PMC_32116663","title":"Role of TG2-Mediated SERCA2 Serotonylation on Hypoxic Pulmonary Vein Remodeling.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32116663","citation_count":25,"is_preprint":false},{"pmid":"27613463","id":"PMC_27613463","title":"Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis.","date":"2016","source":"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27613463","citation_count":24,"is_preprint":false},{"pmid":"24828664","id":"PMC_24828664","title":"TGM2: a cell surface marker in esophageal adenocarcinomas.","date":"2014","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24828664","citation_count":24,"is_preprint":false},{"pmid":"18594942","id":"PMC_18594942","title":"FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.","date":"2008","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/18594942","citation_count":22,"is_preprint":false},{"pmid":"8547071","id":"PMC_8547071","title":"Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis.","date":"1995","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/8547071","citation_count":22,"is_preprint":false},{"pmid":"23685317","id":"PMC_23685317","title":"Electrochemical magneto immunosensor for the detection of anti-TG2 antibody in celiac disease.","date":"2013","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/23685317","citation_count":22,"is_preprint":false},{"pmid":"21046178","id":"PMC_21046178","title":"The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21046178","citation_count":21,"is_preprint":false},{"pmid":"36989728","id":"PMC_36989728","title":"TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36989728","citation_count":20,"is_preprint":false},{"pmid":"23824706","id":"PMC_23824706","title":"Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23824706","citation_count":20,"is_preprint":false},{"pmid":"24212645","id":"PMC_24212645","title":"Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer.","date":"2011","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24212645","citation_count":20,"is_preprint":false},{"pmid":"28199195","id":"PMC_28199195","title":"Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.","date":"2017","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/28199195","citation_count":19,"is_preprint":false},{"pmid":"34485533","id":"PMC_34485533","title":"Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling.","date":"2021","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34485533","citation_count":19,"is_preprint":false},{"pmid":"32006666","id":"PMC_32006666","title":"Blocking TG2 attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting EMT.","date":"2020","source":"Respiratory physiology & neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32006666","citation_count":19,"is_preprint":false},{"pmid":"18594946","id":"PMC_18594946","title":"Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells.","date":"2008","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/18594946","citation_count":18,"is_preprint":false},{"pmid":"10365751","id":"PMC_10365751","title":"Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).","date":"1999","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/10365751","citation_count":18,"is_preprint":false},{"pmid":"16998728","id":"PMC_16998728","title":"Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene.","date":"2006","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/16998728","citation_count":17,"is_preprint":false},{"pmid":"28952066","id":"PMC_28952066","title":"Purification and Characterization of Bacteriocin Produced by a Strain of Enterococcus faecalis TG2.","date":"2017","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28952066","citation_count":17,"is_preprint":false},{"pmid":"9102467","id":"PMC_9102467","title":"Sequence-specific local structural variations in solution structures of d(CGXX'CG)2 and d(CAXX'TG)2 self-complementary deoxyribonucleic acids.","date":"1997","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9102467","citation_count":17,"is_preprint":false},{"pmid":"35617996","id":"PMC_35617996","title":"Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35617996","citation_count":16,"is_preprint":false},{"pmid":"36041715","id":"PMC_36041715","title":"RSL3 triggers glioma stem cell differentiation via the Tgm2/AKT/ID1 signaling axis.","date":"2022","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/36041715","citation_count":16,"is_preprint":false},{"pmid":"37535601","id":"PMC_37535601","title":"TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.","date":"2023","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/37535601","citation_count":16,"is_preprint":false},{"pmid":"28151477","id":"PMC_28151477","title":"Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28151477","citation_count":16,"is_preprint":false},{"pmid":"33245424","id":"PMC_33245424","title":"Enhanced neural differentiation of neural stem cells by sustained release of Shh from TG2 gene-modified EMSC co-culture in vitro.","date":"2020","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/33245424","citation_count":16,"is_preprint":false},{"pmid":"31322240","id":"PMC_31322240","title":"Overexpression of TG2 enhances the differentiation of ectomesenchymal stem cells into neuron‑like cells and promotes functional recovery in adult rats following spinal cord injury.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31322240","citation_count":16,"is_preprint":false},{"pmid":"32069794","id":"PMC_32069794","title":"Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32069794","citation_count":15,"is_preprint":false},{"pmid":"36475545","id":"PMC_36475545","title":"Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36475545","citation_count":15,"is_preprint":false},{"pmid":"33872388","id":"PMC_33872388","title":"High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.","date":"2021","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33872388","citation_count":15,"is_preprint":false},{"pmid":"39788430","id":"PMC_39788430","title":"TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway.","date":"2025","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39788430","citation_count":14,"is_preprint":false},{"pmid":"34731200","id":"PMC_34731200","title":"TG2-gluten complexes as antigens for gluten-specific and transglutaminase-2 specific B cells in celiac disease.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34731200","citation_count":14,"is_preprint":false},{"pmid":"37398884","id":"PMC_37398884","title":"18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway.","date":"2023","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/37398884","citation_count":14,"is_preprint":false},{"pmid":"35014680","id":"PMC_35014680","title":"Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling.","date":"2022","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/35014680","citation_count":13,"is_preprint":false},{"pmid":"34817668","id":"PMC_34817668","title":"ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway.","date":"2021","source":"Lung","url":"https://pubmed.ncbi.nlm.nih.gov/34817668","citation_count":13,"is_preprint":false},{"pmid":"20112034","id":"PMC_20112034","title":"TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/20112034","citation_count":13,"is_preprint":false},{"pmid":"22231926","id":"PMC_22231926","title":"The role of TG2 in ECV304-related vasculogenic mimicry.","date":"2012","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22231926","citation_count":13,"is_preprint":false},{"pmid":"32441391","id":"PMC_32441391","title":"AFF1 inhibits adipogenic differentiation via targeting TGM2 transcription.","date":"2020","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/32441391","citation_count":12,"is_preprint":false},{"pmid":"31830262","id":"PMC_31830262","title":"Hyperglycemia-induced transcriptional regulation of ROCK1 and TGM2 expression is involved in small artery remodeling in obese diabetic Göttingen Minipigs.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31830262","citation_count":12,"is_preprint":false},{"pmid":"18561261","id":"PMC_18561261","title":"The TGM2 gene is associated with schizophrenia in a British population.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18561261","citation_count":12,"is_preprint":false},{"pmid":"33066266","id":"PMC_33066266","title":"Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33066266","citation_count":12,"is_preprint":false},{"pmid":"39580966","id":"PMC_39580966","title":"RSL3 sensitizes glioma cells to ionizing radiation by suppressing TGM2-dependent DNA damage repair and epithelial-mesenchymal transition.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/39580966","citation_count":11,"is_preprint":false},{"pmid":"27864691","id":"PMC_27864691","title":"Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis.","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27864691","citation_count":11,"is_preprint":false},{"pmid":"36872331","id":"PMC_36872331","title":"TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/36872331","citation_count":11,"is_preprint":false},{"pmid":"26636505","id":"PMC_26636505","title":"Mechanism of BMP and TG2 in mesenchymal stem cell osteogenesis.","date":"2015","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26636505","citation_count":11,"is_preprint":false},{"pmid":"20003977","id":"PMC_20003977","title":"Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse.","date":"2009","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/20003977","citation_count":11,"is_preprint":false},{"pmid":"26280645","id":"PMC_26280645","title":"[TGC Repeats in Intron 2 of the TCF4 Gene have a Good Predictive Power Regarding to Fuchs Endothelial Corneal Dystrophy].","date":"2015","source":"Klinische Monatsblatter fur Augenheilkunde","url":"https://pubmed.ncbi.nlm.nih.gov/26280645","citation_count":11,"is_preprint":false},{"pmid":"27562793","id":"PMC_27562793","title":"P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?","date":"2016","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/27562793","citation_count":10,"is_preprint":false},{"pmid":"32456177","id":"PMC_32456177","title":"Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32456177","citation_count":10,"is_preprint":false},{"pmid":"38085503","id":"PMC_38085503","title":"Dioscin Impedes Proliferation, Metastasis and Enhances Autophagy of Gastric Cancer Cells via Regulating the USP8/TGM2 Pathway.","date":"2023","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38085503","citation_count":10,"is_preprint":false},{"pmid":"35041708","id":"PMC_35041708","title":"Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/35041708","citation_count":10,"is_preprint":false},{"pmid":"30522434","id":"PMC_30522434","title":"Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.","date":"2018","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30522434","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54888,"output_tokens":7631,"usd":0.139565},"stage2":{"model":"claude-opus-4-6","input_tokens":11512,"output_tokens":5726,"usd":0.301065},"total_usd":0.44063,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"GPR56 (an adhesion GPCR) binds specifically to tissue transglutaminase TG2 in the extracellular matrix, and this interaction mediates suppression of melanoma tumor growth and metastasis; GPR56 associates in a complex with Gαq and the tetraspanin CD81\",\n      \"method\": \"Binding assay, overexpression/knockdown in melanoma cells, xenograft tumor models\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assay, in vivo xenograft validation, replicated in follow-up study (PMID:24356421)\",\n      \"pmids\": [\"16757564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPR56 internalizes and degrades extracellular TG2, thereby reducing fibronectin deposition and focal adhesion kinase accumulation; TG2 crosslinking activity promotes melanoma growth, while GPR56 antagonizes this by clearing TG2\",\n      \"method\": \"Xenograft studies in immunodeficient Tg2−/− mice, internalization/degradation assays, fibronectin deposition analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic model (Tg2 KO mice), multiple orthogonal readouts, mechanistic follow-up of PMID:16757564\",\n      \"pmids\": [\"24356421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TG2 associates with β1 and β5 integrins on the cell surface of drug-resistant breast cancer cells and promotes fibronectin-mediated focal adhesion kinase activation, conferring an apoptosis-resistant phenotype; siRNA knockdown of TG2 inhibits fibronectin-mediated cell attachment and survival\",\n      \"method\": \"Co-immunoprecipitation (TG2 with β1/β5 integrins), siRNA knockdown, cell survival assays on fibronectin-coated surfaces\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of TG2–integrin complex, siRNA KD with defined phenotype, multiple cell lines\",\n      \"pmids\": [\"16449978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TG2 acts as a G protein mediating intracellular signaling by the α1b-adrenergic receptor in hepatocytes; TG2 knockout mice show increased hepatocyte sensitivity to Fas-mediated apoptosis due to impaired adrenergic signaling and decreased Bcl-xL expression\",\n      \"method\": \"TG2 knockout mouse model, in vivo and in vitro anti-Fas antibody treatment, Bcl-xL expression analysis\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model with defined molecular phenotype (impaired AR signaling, reduced Bcl-xL), replicated in vitro and in vivo\",\n      \"pmids\": [\"16108039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TG2 transamidating/crosslinking activity stimulates NF-κB activation in fibroblasts, leading to increased TGFβ1 expression and secretion, which in turn elevates collagen and fibronectin synthesis and deposition; nitric oxide suppresses TG2 activity and reverses this pro-fibrotic cascade\",\n      \"method\": \"Tetracycline-inducible TG2 expression system in Swiss 3T3 fibroblasts, site-directed TG inhibitors, NF-κB reporter assay, TGFβ1 ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — inducible expression system, site-directed inhibitor, multiple orthogonal readouts (NF-κB reporter, ELISA, Western blot)\",\n      \"pmids\": [\"19657147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TG2 transamidating activity is the primary biochemical function regulating both apoptosis and autophagy; the transamidation-inactive C277S mutant fails to suppress caspase-3/PARP cleavage during apoptosis and fails to catalyze final steps of autophagosome formation\",\n      \"method\": \"TG2 knockout MEF reconstitution with wild-type or C277S transamidation-inactive mutant, apoptosis and autophagy induction assays, LC3-II immunoblot\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis reconstitution in KO cells, multiple orthogonal readouts (caspase-3, PARP, LC3-II)\",\n      \"pmids\": [\"21479826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TG2 directly interacts with β3 integrins on the cell surface (confirmed by immunoprecipitation), acting as a co-receptor for fibronectin; catalytically active TG2 (but not the transamidation-inactive Cys277Ser mutant) activates TGFβ1 and increases fibronectin deposition, enhancing cell adhesion and reducing migration\",\n      \"method\": \"Stable transfection of CT26 cells with wild-type or Cys277Ser TG2, immunoprecipitation of TG2–β3 integrin complex, TGFβ1 measurement, migration assays, site-directed TG inhibitors\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis + Co-IP + multiple functional assays in a defined cell model\",\n      \"pmids\": [\"21046178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TG2 directly binds and crosslinks S100A4, and acts as a substrate enzyme for S100A4 (confirmed by Co-IP, Far Western blotting, and crosslinking assays); TG2-mediated S100A4 crosslinking promotes cell migration through syndecan-4 and α5β1 integrin co-signaling pathways linked by PKCα activation\",\n      \"method\": \"Co-immunoprecipitation, Far Western blotting, in vitro crosslinking assay, shRNA knockdown, TG2-specific inhibitors (cell-permeable and non-cell-permeable), functional blocking antibodies\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding and substrate confirmed by multiple orthogonal methods, pathway dissected with specific reagents\",\n      \"pmids\": [\"23469180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TG2 binds cell surface syndecan-4; inhibition of TG2 transamidating activity by a cell-permeable fluorescent inhibitor blocks TG2 binding to syndecan-4, inhibits TG2 translocation into the extracellular matrix, and reduces fibronectin deposition, cell motility, and cord formation in endothelial cells\",\n      \"method\": \"Cell-permeable fluorescently labeled peptidomimetic TG2 inhibitor, in situ TG2 activity assay, fibronectin deposition analysis, cell motility assays, Matrigel cord formation, mouse model of nephrosclerosis\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific tool compound with direct binding and functional consequences shown in vitro and in vivo\",\n      \"pmids\": [\"26456735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKA-induced phosphorylation of TG2 at serine-216 is required for TG2-mediated NF-κB activation, Akt activation, and PTEN downregulation; a TG2 mutant lacking the Ser216 phosphorylation site (m-TG2) fails to activate NF-κB, fails to promote Akt phosphorylation, and fails to downregulate PTEN\",\n      \"method\": \"TG2 null MEF reconstitution with wild-type or S216A TG2, db-cAMP (PKA activator) treatment, NF-κB reporter assay, Akt immunoblot, PTEN mRNA and protein quantification, MCF-7/T-47D validation\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-directed mutation in KO-reconstitution system, multiple readouts, single lab\",\n      \"pmids\": [\"22759359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TG2, via its protein disulfide isomerase (PDI) activity, triggers trimerization and nuclear translocation of HSF1 and enables HSF1 DNA binding to the HSP70 promoter; TG2 loss impairs HSF1 nuclear translocation and HSP70 induction during proteotoxic stress\",\n      \"method\": \"TG2 loss-of-function (KO/KD), nuclear fractionation, HSF1 DNA binding assay (ChIP/EMSA), cystic fibrosis mouse model lacking TG2, CFTR functional measurement\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (nuclear fractionation, DNA binding, in vivo KO model, functional CFTR readout)\",\n      \"pmids\": [\"29752334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TGM2 installs serotonin onto glutamine-5 of histone H3 (H3Q5ser) via its transamidase activity; histone serotonylation by TGM2 is excluded from constitutive heterochromatic regions because higher-order chromatin structures impose a steric barrier to TGM2 activity, and accessibility rather than primary sequence or pre-existing PTMs dictates TGM2 substrate selectivity at chromatin\",\n      \"method\": \"Biochemical reconstitution with purified TGM2 and nucleosome substrates, DNA-barcoded nucleosome libraries, structure-activity relationship studies, mammalian cell chromatin localization (histone mark profiling)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined substrates, SAR studies, orthogonal cell-based validation\",\n      \"pmids\": [\"36256821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TGM2 promotes formation of mitochondria-associated ER membranes (MAMs) under high-glucose conditions; TGM2 silencing inhibits IP3R1–VDAC1 interactions, preventing mitochondrial calcium influx, mitochondrial ROS accumulation, and amyloid beta production in neuronal cells\",\n      \"method\": \"TGM2 siRNA knockdown, Co-IP of IP3R1–VDAC1, mitochondrial calcium measurement (Fluo-4AM), mtROS quantification, streptozotocin diabetic mouse model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with Co-IP and calcium measurements, in vivo mouse model, single lab\",\n      \"pmids\": [\"32704090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TG2 mediates serotonylation of SERCA2 (sarco-endoplasmic reticulum Ca2+ ATPase) under hypoxic conditions; TG2-mediated SERCA2 serotonylation inhibits SERCA2 activity, increases cytosolic Ca2+ via TRPC6-dependent store-operated calcium entry, and promotes pulmonary vascular smooth muscle cell proliferation; vascular smooth muscle-specific TG2 knockout prevents hypoxic pulmonary hypertension in mice\",\n      \"method\": \"Co-immunoprecipitation of serotonylated SERCA2, TG2 overexpression/silencing, Fluo-4AM intracellular calcium measurement, vascular smooth muscle-specific Tgm2−/− mouse model, RVSP/RVHI measurement\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP demonstrating direct modification, tissue-specific KO mouse model, multiple functional readouts\",\n      \"pmids\": [\"32116663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TG2 forms complexes with NF-κB components and drives constitutive NF-κB activation; under stress, TG2 and NF-κB induce IL-6 production, which in turn activates autophagy to promote mantle cell lymphoma cell survival; ATG5 positively feeds back on the TG2/NF-κB/IL-6 axis\",\n      \"method\": \"CRISPR-mediated TG2 silencing, TG2 overexpression, autophagy flux assays, IL-6 ELISA, NF-κB reporter, ATG5 modulation, in vivo lymphoma models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with multiple pathway readouts, in vivo validation, single lab\",\n      \"pmids\": [\"27488529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"After irradiation, TGM2 is transported from the cell membrane to lysosomes by SDC1, and then TGM2 binds LC3 through two LC3-interacting regions (LIRs), coordinating autophagosome-lysosome fusion by enabling EPG5 recognition of LC3 and stabilizing the STX17-SNAP29-VAMP8 SNARE complex; SDC1-TGM2-FLOT1-BHMT form a complex that maintains autophagic flux in irradiated GBM cells\",\n      \"method\": \"Co-immunoprecipitation, tandem mass tag proteomic analysis, mRFP-GFP-LC3 autophagy flux assay, immunofluorescence, transmission electron microscopy, LIR mutagenesis (implied), in vivo GBM mouse model\",\n      \"journal\": \"Autophagy / Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of multi-protein complex, multiple orthogonal methods (TEM, flux assay, proteomics), in vivo validation, replicated across two publications\",\n      \"pmids\": [\"35913916\", \"37441590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cytosolic TGM2 promotes gastric cancer progression through its GTP-binding enzymatic activity by facilitating dissociation of the ubiquitin E3 ligase TRIM21 from STAT1, thereby preventing TRIM21-mediated ubiquitination and degradation of STAT1 and maintaining STAT1 protein stability\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry identification of TRIM21 as STAT1 E3 ligase, TGM2 GTP-binding mutants, gain/loss-of-function rescue experiments, xenograft and metastasis models, A23187 (Ca2+ ionophore) to modulate TGM2 activity\",\n      \"journal\": \"Cancer communications (London, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP + MS identification + mutagenesis + in vivo, single lab\",\n      \"pmids\": [\"36353796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-1β induces IL-6 production in TG2-expressing breast cancer cells through NF-κB-, PI3K-, and JNK-dependent mechanisms; TG2 expression is required for this IL-1β-driven IL-6 induction and the resulting increase in invasiveness and estrogen-independent tumor growth\",\n      \"method\": \"Stable TG2 transfection in MCF7 cells, cytokine stimulation, anti-IL-6/anti-IL-1β antibody neutralization, 3D culture and in vivo mammary fat pad xenograft\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined genetic model (stable transfection) with antibody neutralization and in vivo validation, single lab\",\n      \"pmids\": [\"27609180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PARP3 promotes TGFβ- and ROS-induced EMT by stimulating a TG2-Snail-E-cadherin axis; PARP3 depletion prevents TGFβ-dependent TG2 induction and downstream Snail upregulation/E-cadherin downregulation\",\n      \"method\": \"PARP3 siRNA depletion, TGFβ treatment, Western blot for TG2/Snail/E-cadherin, migration and chemoresistance assays, stem cell marker analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — epistasis established by siRNA KD with defined pathway readouts, single lab\",\n      \"pmids\": [\"27579892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Missense mutations in TGM2 located close to the catalytic site (M330R, I331N, N333S) impair transamidating activity in vitro and are associated with early-onset type 2 diabetes; TG2 is the only transglutaminase significantly expressed in human pancreatic islet cells\",\n      \"method\": \"TGM2 gene sequencing in MODY/early-onset T2D patients, in vitro transamidation activity assay of mutant proteins, gene expression analysis of TGM family in pancreatic tissue\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay of disease-linked mutants, human tissue expression data, controlled comparison with normoglycemic individuals\",\n      \"pmids\": [\"17939176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TG2 and Factor XIII-A control monocyte-macrophage differentiation into osteoclasts, regulate RANKL production in mesenchymal stem cells and adipocytes, and are required for plasma fibronectin assembly into bone; TG2/FXIII-A double-KO mice show increased osteoclastogenesis, increased bone marrow adipogenesis, and plasma FN retention\",\n      \"method\": \"TG2/FXIII-A knockout mice, in vitro osteoclastogenesis assay, chemical TG activity inhibition, RANKL/OPG expression, biomechanical bone testing, plasma FN assembly assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model in vivo, in vitro rescue with chemical inhibition, multiple orthogonal cellular and molecular readouts\",\n      \"pmids\": [\"28387755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TGM2-mediated serotonylation of glutamine-5 on histone H3 (H3Q5ser) promotes HCC progression; transcriptional intermediary factor 1β (TIF1β) mediates recruitment of TGM2 to MYC target gene loci, facilitating H3Q5ser modification and activating MYC pathway transcription\",\n      \"method\": \"CUT&Tag and RNA sequencing, adeno-associated virus liver-specific TGM2/H3.3 overexpression, TGM2 inhibitor treatment in HCC organoids and xenograft models, hydrodynamic tail vein injection model\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — CUT&Tag chromatin profiling, in vivo liver-specific models, TGM2 inhibitor mechanistic validation, multiple model systems\",\n      \"pmids\": [\"39788430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Weakly migratory breast cancer cells release TG2-enriched microvesicles that activate fibroblasts, leading fibroblast-directed cancer cell migration; microvesicle-TG2 induces tumor stiffening and fibroblast activation in vivo and enhances metastasis of weakly migratory cells\",\n      \"method\": \"Phenotypic cell sorting, microvesicle isolation and proteomic characterization, in vitro migration assays, in vivo tumor stiffening and metastasis models\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proteomic identification of TG2 in microvesicles, in vitro and in vivo functional validation, single lab\",\n      \"pmids\": [\"36475545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TGM2 promotes NF-κB p65 nuclear translocation, which transcriptionally activates fibronectin 1 (FN1); the NEAT1_2 lncRNA sponges miR-491 to regulate TGM2 expression, and TGM2–NFκB–FN1 signaling promotes papillary thyroid cancer invasion and metastasis\",\n      \"method\": \"TGM2 siRNA knockdown, NF-κB p65 nuclear fractionation, dual-luciferase reporter assay (miR-491 binding to NEAT1_2 and TGM2 3'UTR), Transwell and wound healing assays, lung metastasis mouse model\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — nuclear fractionation for mechanism, dual-luciferase for upstream regulation, in vivo model, single lab\",\n      \"pmids\": [\"33738254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In lung-resident neutrophils, prostaglandin E2 (PGE2) acts via protein kinase A (PKA) to induce Tgm2 expression; Tgm2-deficient neutrophils release excessive inflammatory cytokines upon LPS stimulation, and Tgm2−/− mice show exacerbated lung damage in an LPS-induced ARDS model\",\n      \"method\": \"Tgm2 knockout mice, bronchoalveolar lavage fluid treatment of bone marrow neutrophils, LPS challenge, cytokine ELISA, ARDS model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse model, defined signaling pathway (PGE2/PKA/Tgm2), in vivo disease model\",\n      \"pmids\": [\"35679477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Blocking TG2 attenuates bleomycin-induced pulmonary fibrosis by inhibiting EMT; TG2 KD or inhibition suppresses Akt activation, and Akt reactivation (by SC79) rescues the EMT inhibition caused by TG2 knockdown, placing TG2 upstream of Akt in EMT regulation\",\n      \"method\": \"siRNA knockdown of TG2 in MLE12 alveolar epithelial cells, GK921 TG2 inhibitor, SC79 (Akt activator) rescue experiment, bleomycin mouse model, Western blot for EMT markers\",\n      \"journal\": \"Respiratory physiology & neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via rescue experiment, in vivo model, single lab\",\n      \"pmids\": [\"32006666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TGM2 promotes NF-κB signaling in microglia via its GTP-binding activity (not transamidase activity); gain-of-function with transamidase-deficient TGM2 still activates NF-κB and microglial inflammation, whereas GTP-binding-deficient mutant does not\",\n      \"method\": \"TGM2 siRNA knockdown, gain-of-function with GTP-binding vs. transamidase activity mutants, NF-κB signaling assay, LPS-stimulated BV2 and primary microglia\",\n      \"journal\": \"Journal of immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — activity-specific mutagenesis dissecting which enzymatic function mediates NF-κB activation, single lab\",\n      \"pmids\": [\"34485533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AFF1 binds to the promoter region of the Tgm2 gene and directly regulates its transcription; AFF1 inhibition of adipogenic differentiation in mesenchymal stem cells is rescued by Tgm2 overexpression, placing TGM2 downstream of AFF1 in adipogenic regulation\",\n      \"method\": \"ChIP-qPCR (AFF1 at Tgm2 promoter), RNA-seq, AFF1 siRNA/overexpression, Tgm2 overexpression rescue, Oil Red O staining, in vivo adipose formation\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-qPCR establishes direct transcriptional regulation, epistasis by rescue, single lab\",\n      \"pmids\": [\"32441391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RSL3-induced oxidative stress promotes S-glutathionylation of TGM2 via upregulation of GSTP1, leading to proteasomal degradation of TGM2; TGM2 normally accumulates in the nucleus after irradiation and interacts with topoisomerase IIα to facilitate DNA repair; loss of TGM2 through this mechanism impairs DNA DSB repair and inhibits EMT\",\n      \"method\": \"TGM2 overexpression/knockdown, S-glutathionylation assay, nuclear fractionation, TGM2–topoisomerase IIα Co-IP, γ-H2AX foci for DSB quantification, ferroptosis inhibitor controls, xenograft model\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP establishing TGM2–TopIIα interaction, PTM mechanism (S-glutathionylation leading to degradation), nuclear localization with functional consequence, single lab\",\n      \"pmids\": [\"39580966\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TGM2 is a multifunctional Ca2+-dependent enzyme whose transamidase (crosslinking), GTPase/G-protein, protein disulfide isomerase, and kinase activities operate in distinct subcellular compartments: extracellularly/at the cell surface it crosslinks ECM proteins and acts as a co-receptor for fibronectin through β1/β3/β5 integrins and syndecan-4, promoting cell adhesion and survival signaling via FAK and PKCα; intracellularly it acts as a Gαq-like G protein for adrenergic receptors, activates NF-κB (requiring phosphorylation at Ser216 by PKA), stabilizes STAT1 by blocking TRIM21-mediated ubiquitination (via GTP-binding activity), and regulates proteostasis by facilitating HSF1 trimerization/nuclear translocation through PDI activity; in the nucleus it catalyzes monoaminylation (serotonylation) of histone H3 at Q5 in a steric accessibility-dependent manner to activate transcription, and interacts with topoisomerase IIα to facilitate DNA repair; TGM2 also coordinates autophagosome–lysosome fusion by binding LC3 through LIR motifs; it is regulated extracellularly by GPR56-mediated internalization/degradation, by nitric oxide-induced inactivation, and by S-glutathionylation-triggered proteasomal degradation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TGM2 is a multifunctional enzyme whose Ca²⁺-dependent transamidase, GTP-binding, and protein disulfide isomerase activities operate across distinct subcellular compartments to regulate extracellular matrix homeostasis, cell survival signaling, inflammatory responses, chromatin modification, and autophagy. At the cell surface, TGM2 forms complexes with β1/β3/β5 integrins and syndecan-4 to crosslink extracellular matrix proteins including fibronectin and S100A4, activating FAK- and PKCα-dependent adhesion and survival signaling, while GPR56 opposes this by internalizing and degrading extracellular TGM2 [PMID:16449978, PMID:21046178, PMID:26456735, PMID:24356421]. Intracellularly, TGM2 activates NF-κB through either its transamidase or GTP-binding activity depending on cell type, stabilizes STAT1 by blocking TRIM21-mediated ubiquitination via GTP binding, facilitates HSF1 trimerization and nuclear translocation through PDI activity, and coordinates autophagosome–lysosome fusion by binding LC3 through LIR motifs [PMID:19657147, PMID:34485533, PMID:36353796, PMID:29752334, PMID:35913916]. In the nucleus, TGM2 catalyzes serotonylation of histone H3 at Q5 in a chromatin accessibility-dependent manner—with TIF1β mediating recruitment to MYC target loci—and interacts with topoisomerase IIα to facilitate DNA double-strand break repair [PMID:36256821, PMID:39788430, PMID:39580966].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing that TGM2 functions as a cell-surface co-receptor by forming complexes with β1/β5 integrins on cancer cells, linking it mechanistically to fibronectin-mediated FAK activation and drug-resistant survival signaling.\",\n      \"evidence\": \"Co-immunoprecipitation of TGM2–integrin complexes and siRNA knockdown in drug-resistant breast cancer cells\",\n      \"pmids\": [\"16449978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TGM2–integrin interaction unknown\", \"Whether TGM2 transamidase activity is required for integrin binding was not resolved here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying GPR56 as an extracellular TGM2-binding partner that suppresses melanoma growth, establishing that TGM2 in the ECM is subject to receptor-mediated regulation rather than acting autonomously.\",\n      \"evidence\": \"Binding assay and GPR56 overexpression/knockdown in melanoma cells with xenograft validation\",\n      \"pmids\": [\"16757564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of GPR56-mediated TGM2 clearance not yet defined\", \"Whether this applies beyond melanoma was untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that TGM2 functions as an intracellular G protein for α1b-adrenergic receptor signaling in hepatocytes, establishing a non-transamidase role in protecting against Fas-mediated apoptosis through Bcl-xL expression.\",\n      \"evidence\": \"TGM2 knockout mouse model with in vivo and in vitro anti-Fas antibody challenge\",\n      \"pmids\": [\"16108039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TGM2's G-protein function extends to other GPCRs beyond adrenergic receptors was unclear\", \"Structural basis for GTP hydrolysis by TGM2 not characterized\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing that TGM2 transamidase activity directly drives NF-κB activation and a downstream pro-fibrotic TGFβ1–collagen–fibronectin cascade, and that nitric oxide inactivates this pathway.\",\n      \"evidence\": \"Inducible TGM2 expression in fibroblasts with site-directed TG inhibitors, NF-κB reporter, TGFβ1 ELISA\",\n      \"pmids\": [\"19657147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct NF-κB substrate of TGM2 crosslinking not identified\", \"Whether nitric oxide modification is at the active-site cysteine or allosteric was not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolving that catalytically active TGM2, but not the Cys277Ser transamidation-deficient mutant, activates TGFβ1 and fibronectin deposition while interacting with β3 integrins, demonstrating that crosslinking activity is essential for ECM remodeling.\",\n      \"evidence\": \"Stable transfection of wild-type vs. C277S TGM2 mutant, Co-IP of TGM2–β3 integrin complex, functional assays\",\n      \"pmids\": [\"21046178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of TGM2's direct crosslinking substrates in the ECM not comprehensively cataloged\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Using active-site mutagenesis in KO-reconstituted cells to prove that transamidase activity is the primary enzymatic function controlling both anti-apoptotic protection and autophagosome formation.\",\n      \"evidence\": \"TGM2 KO MEF reconstitution with wild-type or C277S mutant, caspase-3/PARP cleavage and LC3-II readouts\",\n      \"pmids\": [\"21479826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets crosslinked during autophagosome formation not identified\", \"Relationship to GTP-binding activity in autophagy regulation not dissected\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying PKA-mediated phosphorylation at Ser216 as a regulatory switch required for TGM2-dependent NF-κB activation, Akt activation, and PTEN downregulation, adding a post-translational control layer to TGM2 signaling.\",\n      \"evidence\": \"S216A mutant reconstitution in TGM2-null MEFs with db-cAMP treatment, NF-κB reporter, Akt/PTEN readouts\",\n      \"pmids\": [\"22759359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Ser216 phosphorylation alters TGM2 conformation or protein interactions was not determined\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating that GPR56 clears extracellular TGM2 via internalization and degradation, mechanistically linking GPR56 tumor suppression to removal of TGM2-dependent fibronectin deposition and FAK signaling.\",\n      \"evidence\": \"Xenograft studies in Tgm2⁻/⁻ mice, internalization/degradation assays\",\n      \"pmids\": [\"24356421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endocytic pathway and degradation compartment for TGM2 not specified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing S100A4 as both a binding partner and crosslinking substrate of TGM2, with TGM2-mediated S100A4 crosslinking driving cell migration through syndecan-4/α5β1 integrin/PKCα co-signaling.\",\n      \"evidence\": \"Co-IP, Far Western, in vitro crosslinking, cell-permeable and non-cell-permeable TG2 inhibitors, shRNA knockdown\",\n      \"pmids\": [\"23469180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific crosslinked S100A4 species identity and stoichiometry not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing that TGM2 transamidase activity is required for TGM2 binding to syndecan-4 and its translocation to the extracellular matrix, establishing syndecan-4 as a gatekeeper for extracellular TGM2 function.\",\n      \"evidence\": \"Cell-permeable fluorescent peptidomimetic TGM2 inhibitor, fibronectin deposition analysis, in vivo nephrosclerosis model\",\n      \"pmids\": [\"26456735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether syndecan-4 is a direct transamidation substrate or binding partner is not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealing that TGM2 forms complexes with NF-κB components and drives constitutive NF-κB activation that feeds into IL-6 production and pro-survival autophagy in lymphoma, establishing a TGM2–NF-κB–IL-6–autophagy circuit.\",\n      \"evidence\": \"CRISPR-mediated TGM2 silencing/overexpression, NF-κB reporter, IL-6 ELISA, autophagy flux, in vivo lymphoma model\",\n      \"pmids\": [\"27488529\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct NF-κB subunit modified or bound by TGM2 not identified\", \"ATG5 feedback mechanism on TGM2/NF-κB not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Establishing that TGM2 and Factor XIII-A jointly regulate osteoclastogenesis, RANKL production, and plasma fibronectin assembly into bone, positioning TGM2 as a key transglutaminase in skeletal homeostasis.\",\n      \"evidence\": \"TGM2/FXIII-A double-KO mice, in vitro osteoclastogenesis, chemical TG inhibition, biomechanical testing\",\n      \"pmids\": [\"28387755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific TGM2 substrates in bone matrix not identified\", \"Individual contributions of TGM2 vs. FXIII-A partially confounded by double KO\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Discovering that TGM2's protein disulfide isomerase activity triggers HSF1 trimerization and nuclear translocation, establishing TGM2 as a proteostasis regulator through a non-transamidase catalytic mechanism.\",\n      \"evidence\": \"TGM2 KO/KD, nuclear fractionation, HSF1 DNA binding assay, cystic fibrosis mouse model\",\n      \"pmids\": [\"29752334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific disulfide bonds in HSF1 rearranged by TGM2 not mapped\", \"Whether PDI activity operates constitutively or only under stress not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that TGM2 promotes mitochondria-associated ER membrane formation under high-glucose conditions by facilitating IP3R1–VDAC1 interactions, linking TGM2 to mitochondrial calcium influx and amyloid beta production in diabetic neurodegeneration.\",\n      \"evidence\": \"TGM2 siRNA KD, Co-IP of IP3R1–VDAC1, mitochondrial calcium measurement, streptozotocin diabetic mouse model\",\n      \"pmids\": [\"32704090\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TGM2 directly crosslinks or scaffolds IP3R1–VDAC1 not determined\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying SERCA2 as a TGM2 serotonylation substrate whose modification under hypoxia inhibits Ca²⁺ reuptake and drives pulmonary vascular smooth muscle proliferation, with vascular smooth muscle-specific Tgm2 KO preventing pulmonary hypertension.\",\n      \"evidence\": \"Co-IP of serotonylated SERCA2, tissue-specific Tgm2⁻/⁻ mice, intracellular calcium measurement, RVSP/RVHI readouts\",\n      \"pmids\": [\"32116663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific glutamine residue(s) on SERCA2 modified by TGM2 not identified\", \"Serotonin source and regulation in pulmonary vasculature not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Dissecting which enzymatic activity mediates NF-κB activation in microglia: GTP-binding activity, not transamidase activity, is responsible, establishing that TGM2's contribution to NF-κB signaling is cell-type and activity-dependent.\",\n      \"evidence\": \"Activity-specific TGM2 mutants (GTP-binding vs. transamidase) in LPS-stimulated BV2 and primary microglia\",\n      \"pmids\": [\"34485533\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target of TGM2's GTP-binding-dependent NF-κB activation not identified\", \"Single lab finding\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Establishing that TGM2 catalyzes histone H3Q5 serotonylation in a chromatin accessibility-dependent manner, with higher-order chromatin structure sterically excluding TGM2 from heterochromatin, defining the epigenetic selectivity principle for this modification.\",\n      \"evidence\": \"Biochemical reconstitution with purified TGM2 and nucleosome substrates, DNA-barcoded nucleosome libraries, mammalian chromatin profiling\",\n      \"pmids\": [\"36256821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reader proteins recognizing H3Q5ser mark not identified in this study\", \"Whether accessibility model extends to other TGM2 histone substrates untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealing that TGM2 coordinates autophagosome–lysosome fusion after irradiation by binding LC3 through LIR motifs, enabling EPG5 recognition and stabilizing the STX17–SNAP29–VAMP8 SNARE complex, within an SDC1–TGM2–FLOT1–BHMT complex.\",\n      \"evidence\": \"Co-IP, tandem mass tag proteomics, mRFP-GFP-LC3 flux assay, TEM, LIR mutagenesis, in vivo GBM model\",\n      \"pmids\": [\"35913916\", \"37441590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TGM2 transamidase or GTP-binding activity is required for SNARE complex stabilization not determined\", \"Generalizability beyond irradiation stress context unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrating that cytosolic TGM2 stabilizes STAT1 by preventing TRIM21-mediated ubiquitination through its GTP-binding activity, providing a mechanism for TGM2-dependent gastric cancer progression independent of transamidase function.\",\n      \"evidence\": \"Co-IP, MS identification of TRIM21, GTP-binding mutants, gain/loss-of-function rescue, xenograft models\",\n      \"pmids\": [\"36353796\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TGM2 directly competes with TRIM21 for STAT1 binding or acts allosterically not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying PGE2/PKA signaling as an upstream inducer of Tgm2 expression in lung-resident neutrophils, with Tgm2 deficiency leading to excessive inflammatory cytokine release and exacerbated lung injury, positioning TGM2 as an anti-inflammatory effector in innate immunity.\",\n      \"evidence\": \"Tgm2 KO mice, BAL fluid treatment, LPS-induced ARDS model, cytokine ELISA\",\n      \"pmids\": [\"35679477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TGM2 substrates mediating cytokine suppression in neutrophils not identified\", \"Whether transamidase or GTP-binding activity mediates the anti-inflammatory effect not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that S-glutathionylation of TGM2 (via GSTP1 upregulation under oxidative stress) triggers its proteasomal degradation and that nuclear TGM2 interacts with topoisomerase IIα to facilitate DNA double-strand break repair, linking TGM2 turnover to DNA repair competence.\",\n      \"evidence\": \"S-glutathionylation assay, nuclear fractionation, TGM2–TopIIα Co-IP, γ-H2AX foci quantification, xenograft model\",\n      \"pmids\": [\"39580966\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of TGM2–TopIIα cooperation in DNA repair not defined\", \"Whether TGM2 crosslinks or scaffolds TopIIα unclear\", \"Single lab finding\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying TIF1β as the chromatin recruiter of TGM2 to MYC target gene loci, where TGM2 catalyzes H3Q5 serotonylation to activate MYC pathway transcription in hepatocellular carcinoma, providing the first recruitment mechanism for TGM2's nuclear epigenetic function.\",\n      \"evidence\": \"CUT&Tag, RNA-seq, liver-specific AAV overexpression, TGM2 inhibitor in HCC organoids and xenografts\",\n      \"pmids\": [\"39788430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TIF1β directly binds TGM2 or acts through intermediaries not fully resolved\", \"Genome-wide scope of TIF1β-dependent TGM2 recruitment beyond MYC targets unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for TGM2's conformational switch between transamidase-active (open/Ca²⁺-bound) and GTP-binding (closed) states in living cells; the identity of direct crosslinking substrates during autophagosome formation; how TGM2 is selectively directed to different subcellular compartments (nucleus, cell surface, ECM, MAMs); and the full catalog of serotonylation targets beyond H3Q5 and SERCA2.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in-cell structural data on TGM2 conformational dynamics\", \"Comprehensive substrate profiling for transamidase and serotonylation activities lacking\", \"Mechanism of TGM2 nuclear import undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 6, 7, 8, 11, 13, 21]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [3, 16, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 16]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [11, 21]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [5, 6, 7, 11, 13, 21]},\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 6, 7, 8]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 8, 22]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 11, 21, 28]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 16, 26]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 9, 14, 17, 23, 26]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [4, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5, 15]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [11, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [28]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [2, 6, 7]}\n    ],\n    \"complexes\": [\n      \"TGM2–integrin (β1/β3/β5) cell-surface complex\",\n      \"TGM2–syndecan-4 complex\",\n      \"SDC1–TGM2–FLOT1–BHMT autophagy complex\"\n    ],\n    \"partners\": [\n      \"FN1\",\n      \"SDC4\",\n      \"ITGB1\",\n      \"ITGB3\",\n      \"GPR56\",\n      \"S100A4\",\n      \"TOP2A\",\n      \"LC3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}